Literature DB >> 10999793

Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster.

A von Eckardstein1, H Schulte, G Assmann.   

Abstract

The criteria of the American Diabetes Association and the WHO for the diagnosis of diabetes mellitus are controversially discussed. In a prospective population study, we evaluated the data of 3,737 men, aged 36-60 yr, without diabetes mellitus and with fasting serum glucose levels less than 7 mmol/L at entry into the study who had at least 1 repeat examination during a follow-up of 4-10 yr. During a mean follow-up of 6.3 yr, 200 men developed diabetes mellitus. They differed significantly from 3,537 men by body mass index, fasting serum levels of glucose, high density lipoprotein cholesterol, and family history positive for diabetes mellitus. Receiver operating curve analysis revealed that a glucose level of 5.72 mmol/L was the best discriminatory cut-off. Upon global risk estimation by multiple logistic function (MLF) analysis, 69.6% of all diabetes mellitus incidences occurred in the highest quintile as defined by the MLF algorithm. The relative risk of a men in this quintile was 8.7 compared to that in the residual population. The performance of risk assessment by MLF as estimated by the area under the receiver operator characteristic curve was similar to fasting glucose levels. Global risk estimation by multiple risk factors does not improve the prediction of diabetes mellitus by fasting glucose in middle-aged men. The lower discriminatory cut-off of 5.72 mmol/L glucose may help to reduce the previously reported discordance between impaired fasting glucose (American Diabetes Association) and impaired glucose tolerance (WHO) in diagnosis of the prediabetic state.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999793     DOI: 10.1210/jcem.85.9.6773

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  46 in total

Review 1.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  4th Annual Symposium on Self Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 12-14, 2011, Budapest, Hungary.

Authors:  Boris N Mankovsky
Journal:  Diabetes Technol Ther       Date:  2011-10-04       Impact factor: 6.118

Review 3.  The emerging role of HDL in glucose metabolism.

Authors:  Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

4.  Aerobic Exercise Prevents Insulin Resistance Through the Regulation of miR-492/Resistin Axis in Aortic Endothelium.

Authors:  Ying Cai; Kang-Ling Xie; Fan Zheng; Sui-Xin Liu
Journal:  J Cardiovasc Transl Res       Date:  2018-09-19       Impact factor: 4.132

5.  Apolipoprotein C-III and its defined lipoprotein subspecies in relation to incident diabetes: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Sarah A Aroner; Jeremy D Furtado; Frank M Sacks; Michael Y Tsai; Kenneth J Mukamal; Robyn L McClelland; Majken K Jensen
Journal:  Diabetologia       Date:  2019-04-04       Impact factor: 10.122

6.  HDL and pancreatic β cells: a SMO-king gun?

Authors:  Liam R Brunham
Journal:  J Lipid Res       Date:  2020-02-07       Impact factor: 5.922

7.  A prediction model for type 2 diabetes risk among Chinese people.

Authors:  K Chien; T Cai; H Hsu; T Su; W Chang; M Chen; Y Lee; F B Hu
Journal:  Diabetologia       Date:  2008-12-05       Impact factor: 10.122

8.  Prediction model for high glycated hemoglobin concentration among ethnic Chinese in Taiwan.

Authors:  Kuo-Liong Chien; Hung-Ju Lin; Bai-Chin Lee; Hsiu-Ching Hsu; Ming-Fong Chen
Journal:  Cardiovasc Diabetol       Date:  2010-09-27       Impact factor: 9.951

9.  Assessing risk for development of diabetes in young adults.

Authors:  Arch G Mainous; Vanessa A Diaz; Charles J Everett
Journal:  Ann Fam Med       Date:  2007 Sep-Oct       Impact factor: 5.166

10.  The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients.

Authors:  G Corona; C B Giorda; D Cucinotta; P Guida; E Nada
Journal:  J Endocrinol Invest       Date:  2013-05-20       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.